84909-43-3

Usage

Uses

Used in Chemical Analysis and Industrial Processes:
4-Methyl-2-quinolinol is used as a chelating agent for its ability to form complexes with metal ions, which is crucial in chemical analysis and various industrial processes. Its chelating properties facilitate the separation, purification, and detection of metal ions, enhancing the efficiency and accuracy of these processes.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 4-Methyl-2-quinolinol is employed as an intermediate in the synthesis of various organic compounds and pharmaceuticals. Its unique structure and reactivity make it a valuable component in the development of new drugs and medicinal agents.
Used in Antiseptic and Disinfectant Products:
4-Methyl-2-quinolinol is utilized in the production of antiseptic and disinfectant products due to its biocidal properties. It helps in the formulation of products that can effectively kill or inhibit the growth of microorganisms, contributing to improved hygiene and sanitation.
Used in Rubber and Plastics Additives Manufacturing:
4-Methyl-2-quinolinol is also used in the manufacturing of additives for rubber and plastics. Its incorporation into these materials can enhance their properties, such as stability, durability, and resistance to environmental factors, thereby improving their performance and longevity.
Due to its diverse applications and chelating properties, 4-Methyl-2-quinolinol holds significant importance across various industries, including chemical analysis, pharmaceuticals, hygiene products, and materials manufacturing.

Upstream product

• 491-35-0 C₆H₄NCH₂CHCCH₂ 
• 4437-65-4 2-mercapto-4-methylquinoline 
• 634-47-9 2-chloro-4-methylquinoline 
• 4053-40-1 4-methylquinoline 1-oxide 
• 108-24-7 acetic anhydride 
• 5234-26-4 N-(2-acetylphenyl)acetamide 
• 141-97-9 ethyl acetoacetate 
• 62-53-3 aniline 
• 1462-03-9 1-methylcyclopentanol 
• 607-66-9 4-methyl-1,2-dihydroquinolin-2-one 
• 67-66-3 chloroform 
• 7732-18-5 water 
• 98-59-9 p-toluenesulfonyl chloride 
• 102-01-2 N-phenylacetoacetamide 

Downstream Products

• 90771-17-8 4-methyl-6-nitro-quinolin-2-ol 
• 7654-51-5 2,2′-biquinoline-4,4′-dicarboxylic acid 
• 90914-95-7 6-amino-4-methylquinolin-2-ol 
• 79140-31-1 4-methyl-2-(4-morpholinyl)quinoline 

Relevant academic research and scientific papers

An environmentally benign one pot synthesis of substituted quinolines catalysed by fluoroboric acid based ionic liquid

Organic synthesis generally required large amount of solvent, avoiding the use of organic solvents in synthesis is a paradigm shift directed at developing more benign chemistry, and with ionic liquids surprisingly can lead to access to new compounds. An elegant one-pot synthesis of quinoline derivatives has been achieved by reaction of substituted anilines with β-ketoester at 60°C in ethanol using an ionic liquid [Et3NH]+[BF 4]- as catalyst. All the reactions gave products with high degree of purity and excellent yield (78.93%) within the shorter span of time (20.65 min) than those reactions with conventional methods. The screening of solvents as well as the reuse of ionic liquid has been evaluated. The structure of the products has been elucidated by spectral and analytical data. The present scope and potential economic impact of the reaction are demonstrated by the synthesis of substituted quinolines. Remaining challenges and future perspectives of the new transformation are discussed.

Computational and Synthetic approach with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S triple mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC)

New substituted quinoline derivatives were designed and synthesized via a five-step modified Suzuki coupling reaction. A comparative molecular docking study was carried out on two different types of EGFR enzymes which include wild-type (PDB: 4I23) and T790M mutated (PDB: 2JIV) respectively. Compounds were also validated upon T790M/C797S mutated (PDB ID: 5D41) EGFR enzyme at the allosteric binding site. All docking studies confirmed high potency and flexibility towards wild type as well as a mutated enzyme. Anticancer activity of the synthesized derivatives was examined against HCC827, H1975 (L858R/T790M/C797S and L858R/T790M), A549, and HT-29 cell lines by standard MTT assay. Most of the quinoline derivatives revealed a significant cytotoxic effect. The IC50 values of 4-(4-methylquinolin-2-yl)phenyl 4-(chloromethyl)benzoate (5j) were found to be 0.0042 μM, 0.02 μM, 1.91 μM, 3.82 μM and 3.67 μM while IC50 values of osimertinib were 0.0040 μM, 0.02 μM, ND, 0.99 μM and 1.22 μM, respectively. Compound 5j has shown excellent inhibitory activities against EGFR kinases triple mutant with IC 50 value 1.91 μM. It was observed that, compared to H1975, A549 and A431 cell lines, synthesized compounds significantly inhibited proliferation of the HCC827 cell line. These data suggested that synthesized compounds showed promising selective anticancer activity against tumor cells harboring EGFR Del E746-A750. The potency of compound 5j was compared through molecular dynamic simulations and an insilico ADMET study. QSAR models were generated and the best model was correctly compared with respect to predicted and observed activity of compounds. The built model will assist to design, refine and construct novel substituted quinoline derivatives as potent EGFR inhibitors in near future.

Free energy perturbation guided Synthesis with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC)

Two different schemes of novel substituted quinoline derivatives were designed and synthesized via simple reaction steps and conditions. A comparative molecular docking study was carried out on two different types of EGFR enzymes which include wild-type (PDB: 4I23) and T790M mutated (PDB: 2JIV) respectively. Compounds were also validated upon T790M/C797S mutated (PDB ID: 5D41) EGFR enzyme at the allosteric binding site. Free energy perturbations were carried out to determine the absolute binding free energy of a protein–ligand complex in the form of ΔGbinding, which in turn provided 4ab and 5ad as the most potential contenders through the structural enhancement in the determined initial scaffolds. Anticancer activity of the synthesized derivatives was examined against HCC827, H1975 (L858R/T790M), A549, and HT-29 cell lines by standard MTT assay. Compound 4ad (6-chloro-2-(isoindolin-2-yl)-4-methylquinoline) has shown excellent inhibitory activities against mutant EGFR kinase with IC50 value 0.91 μM. The potency of compounds 4ab, 4ad and 5ad was compared through an insilico ADMET study.

Discovery, synthesis and molecular substantiation of N-(benzo[d]thiazol-2-yl)-2-hydroxyquinoline-4-carboxamides as anticancer agents

The effort was taken to develop a series of benzothiazole and quinoline fused bioactive compounds obtained through a four-step synthetic route using a range of substituted acetoacetanilides. Achieved N-(benzo[d]thiazol-2-yl)-2-hydroxyquinoline-4-carboxamides (6a-l) were produced up to 96% of yield while the eco-friendly p-TSA used as a catalyst. Further, the anticancer activity of these compounds was determined using a range of cancer cell lines starting from MCF-7 (Breast cancer), HCT-116 (Colon cancer), PC-3 & LNCaP (Prostate) and SK-HEP-1 (Liver cancer). Present study compounds were also testified for antioxidant properties prior to anticancer studies since the Reactive Oxygen Species (ROS) being vital in cancer development. To determine the cell membrane stability effects of the compounds, human red blood cells (HRBC) based membrane protection assay was determined. In the results, compounds 6a-l were able to produce a dominated result values over PC3 cell lines (Prostate cancer) than the other cell lines used in this study. Since the connectivity of human germ cell alkaline phosphatase (hGC-ALP) in the development of prostate cancer is known, the most active compounds were evaluated for the hGC-ALP inhibition in order to ensure a mechanism of anticancer action of these compounds. The mode of interaction and binding affinity of these compounds was also investigated by a molecular docking study. In the results, 6d, 6i, 6k, and 6l were found with least IC50 values 0.075 μM and highest relative activity of 92%, 90%, and 96% respectively. The need for further animal model evaluation and pre-clinical studies recognized.

C-O cross-coupling of activated aryl and heteroaryl halides with aliphatic alcohols

A robust and general catalyst system facilitates the alkoxylation of activated heteroaryl halides with primary, secondary, and select tertiary alcohols without the need for an excess of either coupling partner (see scheme). This catalyst system displays broad functional-group tolerance and excellent regioselectivity, and is insensitive to the order of reagent addition. Copyright

An environmentally benign indium (III) chloride catalysed one-pot synthesis of quinolines

A convenient eco-friendly procedure for the quantitative synthesis of novel quinoline derivatives has been developed by a simple one-pot reaction of substituted anilines with P-ketoesters at 60°C in ethanol using recyclable indium chloride as catalyst. The reaction proceeds smoothly under solvent free conditions with quantitative yields.

A facile synthesis of novel 9-methyl[1,2,3]selenadiazoles[4,5-b]quinoline and 9-methyl[1,2,3]thiadiazole[4,5-b]quinoline as a new class of antimicrobial agents

2-chloro-4-methyl quinoline 2 on condensation with semicarbazide hydrochloride gave its semicarbazone. This on reaction with SeO2 and SOCl2 yielded a new class of novel selenadiazoles 4 and thiadiazoles 5, respectively. The structure of all the compounds were elucidated on the basis of elemental analysis, IR, 1H NMR, and the mass spectral data. Some derivatives of 9-methyl[1,2,3]selenadiazole[4,5-b] quinoline and 9-methyl[1,2,3]thiadiazole [4,5-b]quinoline have been screened for antimicrobial activities. Copyright Taylor & Francis Group, LLC.